Centre Henri Becquerel
65
12
17
35
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.5%
1 terminated/withdrawn out of 65 trials
97.2%
+10.7% vs industry average
6%
4 trials in Phase 3/4
0%
0 of 35 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (65)
Feasibility Study on the Implementation of a Supervised, Home-based Adapted Physical Activity Program for Patients With Head and Neck Cancer
Role: lead
Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis
Role: lead
Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas
Role: lead
Detection of Circulating Tumor DNA in p16- Locally Advanced Head Neck Squamous Cell Carcinoma
Role: lead
Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
Role: lead
Detection of Recurrent Mutations in Waldenström's Disease
Role: lead
Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer
Role: lead
Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Role: lead
Kinetics of Circulating Tumor DNA in Lymphoma Treated by Immuno-chemotherapy
Role: lead
Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells
Role: lead
Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment
Role: lead
Contribution of Residual Tumour DNA Testing on the Surgical Bed
Role: lead
Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA
Role: lead
Interest of Parametric Positron Emission Imaging in the Diagnosis of Infections on Cardiac Valve Prosthesis
Role: lead
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
Role: lead
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
Role: lead
Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma
Role: lead
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
Role: lead
Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients
Role: lead
Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma
Role: lead